Bornstein R A, Nasrallah H A, Olson S C, Coffman J A, Torello M, Schwarzkopf S B
Department of Psychiatry, Ohio State University, Columbus 43210.
Psychiatry Res. 1990 Jan;31(1):15-24. doi: 10.1016/0165-1781(90)90104-d.
Schizophrenic patients were carefully diagnosed and screened for a history of neurological disorders. Diagnosis and subtyping was based on DSM-III-R criteria, using the Structured Clinical Interview for DSM-III-R, which was administered by trained interviewers and confirmed by a research psychiatrist. The schizophrenic patients were compared with an age-matched control group on an extensive battery of neuropsychological measures. The undifferentiated/disorganized schizophrenic patients were consistently the most impaired on a broad range of tasks. When the effect of symptom severity and drug level were statistically controlled (analysis of covariance), however, the magnitude and number of differences were substantially reduced. The perseverative error score from the Wisconsin Card Sort Test showed the greatest difference between the groups. However, the strongest and most consistent effects were observed in relation to symptom ratings. These data indicate the importance of controlling for medication and symptom severity, and suggest that current diagnostic classifications may not be the most useful factors for studies of the cognitive correlates of schizophrenia.
对精神分裂症患者进行了仔细诊断,并筛查了神经疾病史。诊断和亚型分类基于《精神疾病诊断与统计手册》第三版修订版(DSM-III-R)标准,使用针对DSM-III-R的结构化临床访谈,由经过培训的访谈者进行,并由研究精神科医生确认。在一系列广泛的神经心理学测量指标上,将精神分裂症患者与年龄匹配的对照组进行比较。未分化/紊乱型精神分裂症患者在广泛的任务中始终受损最严重。然而,当对症状严重程度和药物水平的影响进行统计学控制(协方差分析)时,差异的大小和数量大幅减少。威斯康星卡片分类测试中的持续性错误分数在两组之间显示出最大差异。然而,在症状评分方面观察到最强且最一致的效应。这些数据表明控制药物和症状严重程度的重要性,并表明当前的诊断分类可能不是精神分裂症认知相关性研究中最有用的因素。